Table 3.

Medication use at end of study follow-up among residents from intervention and control nursing homes

	Total, n=976	Intervention, n=483	Control, n=493	AME (SE) [95% CI]
Proportion of residents with any antipsychotic use in the past week, Mean(SE)	28.1 (1.0) [26.2, 30.0]	26.2 (1.4) [23.4, 29.0]	29.6 (1.3) [27.2, 32.3]	−3.61 (1.85) [−7.22, 0.00]
Proportion of residents with any antidepressant use in the past week, Mean(SE)	58.1 (1.1) [56.0, 60.3]	57.5 (1.5) [54.6, 60.5]	58.8 (1.5) [55.8, 61.7]	−1.26 (2.05) [−5.28, 2.76]
Proportion of residents with any antianxietal use in the past week, Mean(SE)	22.6 (1.2) [20.2, 25.0]	20.8 (1.5) [17.8, 23.8]	24.3 (1.7) [20.9, 27.6]	−3.47 (2.08) [−7.55, 0.06]
Proportion of residents with any medication use in the past week, Mean(SE)	67.1 (1.1) [65.0, 69.2]	66.4 (1.5) [63.5, 69.3]	67.8 (1.5) [64.9, 70.7]	−1.36 (2.02) [−5.33, 2.61]

Abbreviations: SE, standard error; AME, average marginal effect

Variables included in the model: baseline medication use, age, sex, race, activities of daily living score, cognitive function score, psychotic diagnosis, depression, anxiety, dementia, asthma, Agitated and Reactive Behavior Scale, date of assessment, treatment group, and facility level random effect.